comparemela.com
  1. Home
  2. Live Updates
  3. Mohamad Kassab - Breaking News

Latest Breaking News On - Mohamad kassab - Page 1 : comparemela.com

Amarin Corporation plc: Amarin Highlights New Data Providing Potential Mechanistic Insight into Vascepa®/Vazkepa® (Icosapent Ethyl) Reduction of Cardiovascular Events

- New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression - Data Further Advances Understanding of VASCEPA/VAZKEPA Potential Mechanism

United statesLoyola universityNew jerseyUnited arab emiratesMark marmurColl cardiolMarkg rabbatMohamad kassabNabil abadirClin cardiolLisa defrancescoFarouc jafferAmarin pharmaceuticals irelandJournal of the american college cardiologyAmerican heart associationExchange commission

Amarin Highlights New Data Providing Potential Mechanistic Insight into Vascepa®/Vazkepa® (Icosapent Ethyl) Reduction of Cardiovascular Events

— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — Data Further Advances Understanding of VASCEPA/VAZKEPA. | May 12, 2023

United arab emiratesUnited statesNew jerseyLoyola universityClin cardiolNabil abadirFarouc jafferLisa defrancescoMohamad kassabMarkg rabbatMark marmurColl cardiolDrug administrationCorporate communicationsHead of global medical affairsResearch demonstrates multifactorial beneficial

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.